Lumexa Imaging Holdings, Inc.

LMRI Healthcare Medical Devices

Lumexa Imaging Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 billion, up 7.82% from fiscal 2024. In the quarter to June 2026, revenue grew 7.82%, EPS grew 127.1% and free cash flow grew 257.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

10.64 0.14 −1.30%
Market cap
$1.0B
P/E
0.0×
Fwd P/E
14.2×
Dividend yield
—
F-score
n/a
Altman Z
0.96
Beneish M
−2.67
Dividend safety
n/a
Older periods Jun '25 Dec '25 Mar '26 Jun '26
ROE

+3 more TTM periods

— — 0.00% 0.00%
ROA
— 0.00% (3.51%) (5.51%)
ROIC
0.00% 0.00% 48.32% 48.10%
Return on Tangible Assets
— 0.00% (28.17%) (21.30%)
Average Days of Receivables
— 0.00 31.75 35.09
Free Cash Flow per Share
0.14 (0.10) (0.24) 0.16
Free Cash Flow
10.04 (7.22) (22.88) 14.93
Other line items

Show all line items

Columns are period end dates